Cancer of the penis. Our experience in 15 years;Cáncer de pene. Nuestra experiencia en 15 años

Actas Urologicas Espanolas

Volumn 33, Issue 2, 2009, Pages 143-148

  Di Capua Sacoto, Carlos ^a   Marco, Sátur Lujan ^a   Solchaga, Gonzalo Morales ^a   Alba, Alberto Budía ^a   Pontones Moreno, José L ^a   Jiménez Cruz, Juan F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cancer; Penis; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; HUMAN; MALE; MIDDLE AGED; PENIS TUMOR; RETROSPECTIVE STUDY; TIME;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PENILE NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 66149184655     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(09)74114-2     Document Type: Article

References (34)

1. Solsona E. Cáncer de pene. Actas Urol Esp. 2002;26(8):525-531.
2. Rlppentrop JM, Joslyn SA, Konety BR. Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program. Cancer. 2004; 101(6): 1357-1363.
3. Peyrí Rey E. Prevención del cáncer de pene. Actas Urol Esp. 2008;32(4):470-471.
4. Soto Delgado M, Arredondo Martinez F, Pedrero Márquez G, Basquero González B, Zurera Cosano A, Linares Armada R. Cáncer de pene. Una revisión de 18 casos. Actas Urol Esp. 2003;27(10):797-802.
5. Donald F. Lynch and Curtis A. Pettaway. Tumors of the penis. Cambell of Urology. Walsh P, Retlk A, Vaughan E, Weln A, Kavossl L, Novick A, Partln A. and Peters C. 8 edlclon, 2004;3225-3265.
6. Wiener JS, Walther PJ. The association of oncogenic human paplllo-maviruses with urologic malignancy. Surg Oncol Clin North Am. 1995;4(2):257-276.
7. Boshart M, zur Hausen H. Human papillomaviruses (HPV) in Buschke-Lowenstein tumors: Physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype. J Virol. 1986;58(3):963-966.
8. Castellsagué X, Ghaffari A, Daniel RW, Bosch FX, Muñoz N, Shah KV. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis. 1997;176(2):353-361.
9. Shapiro E. American Academy of Pediatrics policy statements on circumcision and urinary tract infection. Rev Urol. 1999; 1(3): 154-156.
10. Cruz Guerra NA, Allona Almagro A, Clemente Ramos L, Linares Quevedo A, Briones Mardones G, Escudero Barrilero A. Linfadenectomia en el carcinoma escamoso de pene: revision de nuestra serie. Actas Esp Urol. 2000;24(9):709-714.
11. Solsona E, Algaba F, Horenblas S, Pizzocaro G, Wlndahl T; European Association of Urology. EAU guidelines on penile cancer. Eur Urol 2004;46(l):l-8.
12. Sklaroff RB, Yagoda A. Penile cancer: Natural history and therapy. In Spiers ASD, ed: Chemotherapy and Urological Malignancy. New York, Springer -Verlag, 1982:98-105.
13. Malakoff AF, Schmidt JD. Metastatic carcinoma of penis complicated by hypercalcemia. Urology. 1975;5(4):510-513.
14. Rubio-Briones J, Villavlcencio H, Regalado R, Chéchile G, Algaba F, Monreal F, et al. Carcinoma escamoso de pene; protocolo de tratamiento según nuestra experiencia en 14 anos. Arch Esp Urol. 1997;50(5):473-480.
15. Leijte JA Klrrander P, Antonlnl N, Wlndahl T, Horenblas S. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008;54(1): 161-169.
16. Solsona E, Iborral, Rublo J, Casanova JL, Ricos J V, Calabulg C. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node mlcrometastasls In patients with penile carcinoma and clinically negative Inguinal lymph nodes. J Urol. 2001;165(5): 1506-1509.
17. Ornellas AA, Selxas AL, Marota A, Wisnescky A, Campos F, de Moraes JR. Surgical treatment of Invasive squamous cell carcinoma of the penis: Retrospective analysis of 350 cases. J Urol. 1994;151(5):1244-1249.
18. Puras-Baez A, Rlvera-Herrera J, Miranda G, et al: Role of superficial Inguinal lymphadenectomy In carcinoma of the penis. J Urol. 1995; 153:246.
19. Anderson EE, Glenn JF. Penile malignancy and hypercalcemia. JAMA. 1965;192:328-329.
20. Bleeker MC, Heldeman DA, Snljders PJ, Horenblas S, Dlllner J, Meljer CJ. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2008;8.
21. Cuevas J, de Euseblo E, Dlez E, Castiñelra I. Mohs mlcrographlc surgery: apllcatlon of this technique to penile neoplasms. Actas Urol Esp. 2007; 31(9):1076-1081.
22. Meljer RP, Boon TA, van Venroolj GE, Wljburg CJ. Long-term follow-up after laser therapy for penile carcinoma. Urology. 2007;69(4):759-762.
23. Mohs FE, Snow SN, Larson PO. Mohs mlcrographlc surgery for penile tumors. Urol Clin North Am. 1992; 19(2):291-304.
24. Velazquez EF, Ayala G, Liu H, Chaux A, Zanottl M, Torres J, et al. Histologic grade and perineural Invasion are more Important than tumor thickness as predictor of nodal metastasis In penile squamous cell carcinoma Invading 5 to 10 mm. Am J Surg Pathol. 2008;32(7):974-979.
25. Cubllla AL Meljer CJ, Young RH. Morphological features of epithelial abnormalities and precancerous lesions of the penis. Scand J Urol Nephrol. 2000;(205):215-219.
26. Velazquez EF, Piris A, Cubllla. A high grade squamous intraepltellal lesion of the penis: morphologic subtypes corralate with homologous variants of invasive squamous cell carcinoma, a report 126 cases. Mod Path. 2001;14: 126.
27. Lont AP, Kroon BK, Gallee MP, van Tinteren H, Moonen LM, Horenblas S. Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol. 2007; 177(3):947-952.
28. Hegarty PK, Kayes O, Freeman A, Christopher N, Ralph DJ, Minnas S. A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines. BJU Int. 2006;98(3):526-531.
29. Novara G, Artlbani W, Cunico SC, De Giorgi G, Gardiman M, Martignoni G, et al. How accurately do Solsona and European Association of Urology risk groups predict for risk of lymph node metastases in patients with squamous cell carcinoma of the penis? Urology. 2008;71(2):328-333.
30. Bevan-Thomas R Slaton JW, Pettaway CA. Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: The M. D. Anderson Cancer Center experience. J Urol. 2002;167(4):1638-1642.
31. Heyns CF, Theron PD. Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes. BJU Int. 2008; 102(3):305-309.
32. Hadway P, Smith Y, Corbishley C, Heenan S, Watkin NA. Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma. BJU Int. 2007;100(3):561-565.
33. Kroon BK, Horenblas S, Lont AP, Tanis PJ, Gallee MP, Nieweg OE. Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol. 2005:173(3):816-819.
34. Johnson DE, Lo RK. Management of regional lymph nodes in penile carcinoma. Five-year results following therapeutic groin dissections. Urology 1984;24(4):308-311.